Newsroom

WESTLAKE VILLAGE, Calif.--(BUSINESS WIRE)--Velocity Financial, Inc. (NYSE: VEL) (“Velocity” or the “Company”), a leader in investor real estate loans, today announced the closing of Velocity Commercial Capital, LLC’s, a wholly-owned subsidiary of Velocity (the “Issuer”), previously announced offering of $500 million aggregate principal amount of 9.375% Senior Notes due 2031 (the “Notes”) which was sold at an offering price equal to 100% of the principal thereof in an offering exempt from regist...

CHICAGO--(BUSINESS WIRE)--CCC Intelligent Solutions Inc. (CCC), a leading cloud platform provider powering the P&C insurance economy, today announced the appointment of Josh Valdez as Chief Product Officer. Valdez will lead CCC’s product strategy, design, and delivery, with responsibility for scaling AI-driven technology and innovation across the company’s platform to accelerate value for customers. Valdez is an experienced product innovator with a strong background in both building and sca...

NEW YORK--(BUSINESS WIRE)--TPG Mortgage Investment Trust, Inc. (NYSE: MITT) (the “Company”) announced today the tax treatment of common and preferred stock distributions paid to stockholders. This information is provided to assist stockholders with tax reporting requirements related to distributions of taxable income by the Company. Stockholders should review the 2025 tax statements and/or Form 1099-DIV received from their brokerage firms or other institutions to ensure those statements agree w...

WILSONVILLE, Ore.--(BUSINESS WIRE)--ESS Tech, Inc. Announces Closing of $15 Million Registered Direct Offering Priced at a Premium to Market...

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT) will hold its earnings call and webcast to discuss 2025 fourth quarter and year-end results at 8:30 a.m. CST on Friday, February 13, 2026. Investors may access the live webcast on the Company’s web site at investor.sensient.com. Alternatively, investors may join the conference call by contacting Chorus Call Inc. at (844) 492-3726 or (412) 317-1078. A webcast replay will be available on the Company’s web site following the...

MONTEVIDEO, Uruguay--(BUSINESS WIRE)--Arcos Dorados B.V. (the “Company”) today announced that it has commenced a cash tender offer to purchase up to $150 million aggregate principal amount (such amount, as the same may be increased in the sole discretion of the Company, the “Maximum Tender Amount”) of its outstanding 6.125% Sustainability-Linked Senior Notes due 2029 (the “Notes”) (the “Offer”). The complete terms and conditions of the Offer are set forth in the offer to purchase dated January...

NEW YORK--(BUSINESS WIRE)--Ares Capital Corporation (“Ares Capital” or the “Company”) (NASDAQ: ARCC) announced today the tax treatment of the Company’s 2025 common stock distributions (CUSIP #: 04010L103).       Ordinary Income Per Share     Record Date Payable Date Total Paid Per Share Ordinary Rate 20% Rate (1) Long Term Capital Gains per Share (2) Interest - Related Dividends (3) 3/14/2025 3/31/2025 $ 0.4800 $ 0.339128 $ 0.140872 $ 0.0000 84.7500% 6/13/2025 6/30/2025 $ 0.4800 $ 0.339128 $ 0....

MORGES, Schweiz--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) hat heute bekannt gegeben, dass das Committee for Medicinal Products for Human Use (CHMP) der Europäischen Arzneimittelagentur (European Medicines Agency, EMA) eine positive Stellungnahme abgegeben hat, in der die Zulassung von Zynyz® (Retifanlimab) in Kombination mit Carboplatin und Paclitaxel (platinbasierte Chemotherapie) zur Erstlinienbehandlung von erwachsenen Patienten mit metastasiertem oder inoperablem lokal rezidivierendem Platten...

MORGES, Svizzera--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) oggi ha annunciato che il Comitato per i medicinali per uso umano (CHMP) dell'Agenzia europea per i medicinali (EMA) ha rilasciato il parere favorevole che ha raccomandato l'approvazione di Zynyz® (retifanlimab) in combinazione con carboplatino e paclitaxel (chemioterapia a base di platino) per il trattamento di prima linea di pazienti adulti con carcinoma anale squamocellulare (SCAC) localmente ricorrente metastatico o inoperabile. Il tes...

MIAMI--(BUSINESS WIRE)--Ocean Bank today announced double-digit growth in assets, deposits and stockholder’s equity for 2025, compared to year-end 2024. Total assets reached $7.44 billion, an increase of 11 percent during the year, while deposits grew 12 percent to $6.27 billion. “This growth reflects Ocean Bank’s constant dedication to meeting our customers’ needs,” said Agostinho Alfonso Macedo, President, Chairman and CEO of Ocean Bank. “Strong customer relationships drove increases in loans...